CD8A and neoplasm: Combination of IL‐21 with anti‐PD‐1 or anti‐CTLA‐4 therapy in animal tumor models resulted in the augmented intra‐tumoral infiltration of CD8+ T cells, along with their increased proliferation and a higher proportion of effector memory T cells.77